NASDAQ : MMSI

Merit Medical Systems, Inc.

$85.01 USD

$1.66 (1.99%)

Volume
2.2M
Average Volume
854.34K
Market Capitalization
$5.08B
P/E Ratio
34.70
Dividend Yield
0.00%
Price Target
$100.00
Year High
$94.75
Year Low
$59.74
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.20
Company Overview

NASDAQ

Martha Goldberg Aronson

Medical - Instruments & Supplies

Healthcare

MMSI

7500

US

USD

https://www.merit.com

801 253 1600

589889104

0000856982

Liquidity Metrics

0.52

4.20

2.79

1.69

0.00

Sales & Valuation

$1.51B

3.21

3.02

24.94

3.41

Profitability

$2.13

$128.49M

9.22%

12.31%

9.07%

5.08%

P/E Metrics

34.70

1.68

1.68

Analyst Price Target & Rating

$100.00

$114.00

$78.00

Neutral

3/5

15 Analysts

-14.99%

Financial Health Scores

4.18

6/9

$847.3M

$2.86B

$1.18B

$226.22M

Key Metrics (TTM)

$5.49B

3.48

15.17

4.20

9.07%

5.78%

2.87%

4.01%

$39.30

229 days

Company Executives
Name Title
Mark Butler Executive Vice President of Merit Medical EMEA
Neil Peterson Chief Operating Officer
Raul Parra Jr. Chief Financial Officer & Treasurer
Jason Treft Chief Information Officer
Michel J. Voigt Chief Human Resources Officer
John Knorpp Chief Regulatory Affairs Officer
Martha Goldberg Aronson President, Chief Executive Officer & Director
Sarah Comstock Vice President of Global Communications
Ricardo Alvarez Managing Director of Operation Merit Medical Tijuana
Brian G. Lloyd Chief Legal Officer & Corporate Secretary
Poll Results

No votes yet today — be the first to share your view!

About Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various i ... nterventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.

MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised

2026-07-31 12:11:04

Merit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results

2026-07-31 06:43:36

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday.

Merit Medical Systems, Inc. (MMSI) Q2 2026 Earnings Call Transcript

2026-07-30 22:43:21

Merit Medical Systems, Inc. (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical (MMSI) Surpasses Q2 Earnings and Revenue Estimates

2026-07-30 19:06:15

Merit Medical (MMSI) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.01 per share a year ago.

Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

2026-07-30 19:00:50

The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

2026-07-30 16:05:00

Financial Highlights† Reported revenue of $418.8 million, up 10% Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectively GAAP operating margin of 14.4%, compared to 12.3% in prior year period Non-GAAP operating margin* of 22.6%, compared to 21.2% in prior year period GAAP EPS $0.65, up 20% Non-GAAP EPS* $1.19, up 18% Cash flow from operations of $110.0 million year-to-date, down 11% Free cash flow* generation of $76.6 million year-to-date, down 14% † Comparisons above are calculated for the current quarter compared with the second quarter of 2025, unless otherwise specified. Amounts stated in this release are rounded, while percentages are calculated from the underlying amounts.

Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?

2026-07-29 11:56:11

Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.

Allspring Global Investments Holdings LLC Sells 32,413 Shares of Merit Medical Systems, Inc. $MMSI

2026-07-28 03:49:56

Allspring Global Investments Holdings LLC cut its holdings in shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) by 75.1% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,751 shares of the medical instruments supplier's stock after selling 32,413 shares during the

Frequently Asked Questions

What is the current Merit Medical Systems, Inc. (MMSI) stock price?

Merit Medical Systems, Inc.(NASDAQ:MMSI) stock price is $85.01 in the last trading session. During the trading session, MMSI stock reached the peak price of $94.75 while $59.74 was the lowest point it dropped to. The percentage change in MMSI stock occurred in the recent session was 1.99% while the dollar amount for the price change in MMSI stock was $1.66.

MMSI's industry and sector of operation?

The NASDAQ listed MMSI is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of MMSI?

Mark Butler | Executive Vice President of Merit Medical EMEA
Neil Peterson | Chief Operating Officer
Raul Parra Jr. | Chief Financial Officer & Treasurer
Jason Treft | Chief Information Officer
Michel J. Voigt | Chief Human Resources Officer

How many employees does MMSI have?

Number of MMSI employees currently stands at 7500. MMSI operates from 1600 West Merit Parkway, South Jordan, UT 84095, US.

Link for MMSI official website?

Official Website of MMSI is: https://www.merit.com

How do I contact MMSI?

MMSI could be contacted at phone #801 253 1600 and can also be accessed through its website. MMSI operates from 1600 West Merit Parkway, South Jordan, UT 84095, US.

How many shares of MMSI are traded daily?

The average number of MMSI shares traded daily for last 3 months was 854.34K.

What is the market cap of MMSI currently?

The market value of MMSI currently stands at $5.08B with its latest stock price at $85.01